| 1. IDENTIFICATION & BASIC DESCRIPTION |
|
Cohort name
|
| |
The Cement Australia Railton Study
|
|
Country
|
| |
|
|
Name
|
| |
Prof Malcolm Sim
|
|
Institution
|
| |
Monash University
|
|
Email
|
| |
malcolm.sim@monash.edu
|
|
Personal website
|
| |
https://research.monash.edu/en/persons/malcolm-sim
|
|
Do you want to add another Principal Investigator of the Cohort
|
| |
- Add another Principal Investigator of the cohort
|
|
Name
|
| |
Dr Geza Benke
|
|
Institution
|
| |
Monash University
|
|
Email
|
| |
Geza.Benke@monash.edu
|
|
Personal website
|
| |
https://research.monash.edu/en/persons/geza-benke
|
|
Do you want to add another Principal Investigator of the Cohort
|
| |
- Add another Principal Investigator of the cohort
|
|
Name
|
| |
Dr Ewan MacFarlane
|
|
Institution
|
| |
Monash University
|
|
Email
|
| |
Ewan.MacFarlane@monash.edu
|
|
Personal website
|
| |
https://research.monash.edu/en/persons/ewan-macfarlane
|
|
Website
|
| |
- https://www.monash.edu/medicine/sphpm/coeh/research/cement-australia-railton-study
|
|
Name of committee
|
| |
Monash University Human Research Ethics Committee
|
|
Or provide website
|
| |
- https://www.monash.edu/medicine/sphpm/coeh/research/cement-australia-railton-study
|
|
Contact Principal Investigator (name)
|
| |
Malcolm Sim
|
|
Main aim of cohort, please briefly describe the main objectives of the cohort
|
| |
Investigation into cancer and mortality at the Cement Australia Railton facility in Tasmania.
|
|
Study design (please select as many as appropriate)
|
| |
|
|
Source population (please select as many as appropriate)
|
| |
- Industry / occupation-based
|
|
Comparators (please select as many as appropriate)
|
| |
- External study population (includes SMR/SIR studies)
|
|
Inclusion criteria
|
| |
Current or former workers from cement manufacturing plant in Tasmania
|
|
Exclusion criteria
|
| |
Only current employees were given the option of opting out of the study, the rest of the cohort was automatically included, but never contacted.
|
|
Enrollment
|
| |
Ongoing
|
|
Age range at entry (main cohort)
|
| |
|
|
Age range at entry (subcohort)
|
| |
| Minimum |
Maximum |
Mean |
Please describe |
| >18 |
|
|
|
|
| 2. OUTCOME FOLLOW-UP |
|
Type of data for outcome follow-up (please select as many as appropriate)
|
| |
|
|
Death certificate (specify)
|
| |
- Data linkage with the National Death Index. Five- to ten-year intervals, funding dependent.
|
|
First follow-up period (provide year)
|
| |
2010-2011
|
|
Number of follow-ups after baseline (provide number)
|
| |
1
|
| 3. OCCUPATIONAL EXPOSURES |
|
Source of exposure data collected (please select as many as appropriate)
|
| |
- Questionnaire, Personal (Self-reporting or interview)
- Questionnaire, Personal (Occupational/industry modules)
- Job-employment records
|
|
Occupational history/time frame
|
| |
Lifetime
|
|
Occupational coding performed
|
| |
No
|
|
Methods for exposure assessment (please select as many as appropriate)
|
| |
|
|
Main categories
|
| |
|
|
Main categories | Other | Specify: Other
|
| |
Asbestos
|
|
Comments
|
| |
This cohort study tracks cancer and mortality of current and former workers at a cement manufacturing plant which previously produced asbestos-cement products in Railton, Tasmania. Although the use of asbestos was phased out at Railton in the 1980s, risk of health effects among this workforce may still remain because asbestos-related diseases may not emerge until many years after exposure.
|
| 4. OUTCOMES EVALUATED |
|
Baseline - type of outcome data collected (select more than one if applicable)
|
| |
- Death certificates
- Questionnaire, individual (self-recording or interview)
|
|
Follow-up - type of outcome data collected (select more than one if applicable)
|
| |
|
|
Outcome type (please select as many as appropriate)
|
| |
|
|
Diagnostic groups based on ICD10
|
| |
|
|
C + D Neoplasms
|
| |
- Malignant neoplasms gastro intes. system including liver, gall bladder, pancreas
- Malignant neoplasm lung
|
| 6. Other Information |
|
|
| |
- Alcohol
- Demographics
- Smoking
|
|
Possibility for linkage to data registries/data enrichment via data linkage
|
| |
- Cancer incidence
- Mortality register
|